Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QFL3
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016791 | phosphatase activity | 5 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.721 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.326 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.533 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.755 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.325 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.533 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.755 |
CLV_PCSK_PC7_1 | 119 | 125 | PF00082 | 0.725 |
CLV_PCSK_SKI1_1 | 252 | 256 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.370 |
DEG_SCF_SKP2-CKS1_1 | 202 | 209 | PF00560 | 0.344 |
DOC_ANK_TNKS_1 | 22 | 29 | PF00023 | 0.571 |
DOC_PP1_RVXF_1 | 147 | 153 | PF00149 | 0.444 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.787 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.777 |
DOC_WW_Pin1_4 | 203 | 208 | PF00397 | 0.372 |
LIG_14-3-3_CanoR_1 | 69 | 73 | PF00244 | 0.473 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.558 |
LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.444 |
LIG_EH1_1 | 239 | 247 | PF00400 | 0.396 |
LIG_FHA_1 | 198 | 204 | PF00498 | 0.344 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.481 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.457 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.684 |
LIG_FHA_2 | 13 | 19 | PF00498 | 0.366 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.338 |
LIG_FHA_2 | 178 | 184 | PF00498 | 0.344 |
LIG_GBD_Chelix_1 | 8 | 16 | PF00786 | 0.392 |
LIG_Integrin_isoDGR_2 | 114 | 116 | PF01839 | 0.704 |
LIG_LIR_Gen_1 | 185 | 195 | PF02991 | 0.403 |
LIG_LIR_Gen_1 | 215 | 221 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 164 | 169 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 185 | 191 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 215 | 220 | PF02991 | 0.429 |
LIG_MYND_1 | 2 | 6 | PF01753 | 0.587 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.344 |
LIG_PTB_Apo_2 | 73 | 80 | PF02174 | 0.510 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.410 |
LIG_SUMO_SIM_par_1 | 199 | 206 | PF11976 | 0.345 |
LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.717 |
LIG_TRAF2_1 | 97 | 100 | PF00917 | 0.670 |
MOD_CDK_SPxK_1 | 203 | 209 | PF00069 | 0.344 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.330 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.434 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.628 |
MOD_CK2_1 | 12 | 18 | PF00069 | 0.375 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.769 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.494 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.780 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.753 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.800 |
MOD_GlcNHglycan | 133 | 138 | PF01048 | 0.638 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.625 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.321 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.412 |
MOD_N-GLC_1 | 81 | 86 | PF02516 | 0.632 |
MOD_NEK2_1 | 12 | 17 | PF00069 | 0.372 |
MOD_PIKK_1 | 182 | 188 | PF00454 | 0.441 |
MOD_PKA_1 | 124 | 130 | PF00069 | 0.686 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.375 |
MOD_PKA_2 | 124 | 130 | PF00069 | 0.686 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.438 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.444 |
MOD_Plk_1 | 182 | 188 | PF00069 | 0.429 |
MOD_Plk_1 | 229 | 235 | PF00069 | 0.343 |
MOD_Plk_1 | 32 | 38 | PF00069 | 0.541 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.723 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.375 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.392 |
MOD_Plk_4 | 230 | 236 | PF00069 | 0.343 |
MOD_ProDKin_1 | 203 | 209 | PF00069 | 0.372 |
MOD_SUMO_for_1 | 228 | 231 | PF00179 | 0.399 |
TRG_DiLeu_BaLyEn_6 | 3 | 8 | PF01217 | 0.460 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 124 | 126 | PF00400 | 0.721 |
TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.325 |
TRG_ER_diArg_1 | 235 | 238 | PF00400 | 0.366 |
TRG_ER_diArg_1 | 256 | 258 | PF00400 | 0.552 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3Q2 | Leptomonas seymouri | 59% | 94% |
A0A0S4IS02 | Bodo saltans | 42% | 100% |
A0A1X0NNH3 | Trypanosomatidae | 39% | 100% |
A0A3R7R775 | Trypanosoma rangeli | 42% | 100% |
A0A3S7WT65 | Leishmania donovani | 91% | 100% |
A4H7U1 | Leishmania braziliensis | 71% | 94% |
A4HW67 | Leishmania infantum | 91% | 100% |
E9APW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |